Asieris Pharmaceuticals
We strive for healthy and dignified lives!
United States
60 employees
Series D
Total: $1.19B
Biotechnology, Health Care +1
General Information
Get notified when Asieris Pharmaceuticals moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Asieris Pharmaceuticals
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biotechnology
About Asieris Pharmaceuticals
Taxonomy: pharmaceuticals, biotech, drug development, oncology, genitourinary tumors, global healthcare, R&D, innovation, clinical research, therapeutic areas, diagnosis and treatment solutions, strategic partnerships, multidrug-resistant infections, unmet clinical needs
Funding Rounds & Investors (5)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series D | •••••• | 10 |
|
11 Nov 2020 |
| Series C | •••••• | - | 28 Jun 2020 | |
| Series C | •••••• | - | 24 Mar 2020 | |
| Series B | •••••• | - | 27 Dec 2017 | |
| Series A | •••••• | - | 12 Dec 2016 |
Asieris Pharmaceuticals Alternatives & Competitors
Develops, manufactures, and markets a variety of medicines and medicine packing materials
A biopharmaceutical company with a focus on developing its first drug candidate for patients with Cy...
🫁 Improving the health and lives of patients through effective, safe and convenient inhaled drug de...
FAQ About Asieris Pharmaceuticals
Don't just browse. Track.
Signal Tracker monitors Asieris Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.